CCGs to be monitored on cancer diagnostics access

CCG performance on access to cancer scans is set to be tracked under a new range of indicators from NICE.

CCGs will be judged on access to ultrasound diagnostics (Photo: Science Photo Library)
CCGs will be judged on access to ultrasound diagnostics (Photo: Science Photo Library)

Timely access to diagnostics for ovarian and colorectal cancers will be tracked as part of 28 new proposed indicators to monitor CCGs' performance.

These will measure how many women with raised CA125 levels have an ultrasound within two weeks, and how many colon cancer patients receive diagnostic colonoscopy.

Other indicators will cover asthma deaths, antenatal care and diabetes care for children.

The measures are proposed as part of the CCG Outcomes Indicator framework for 2015/16. The framework benchmarks performance to help CCGs improve care outcomes, and hold them publicly to account.

NICE has launched a consultation on the proposals, which ends on Monday 3 March. A final indicator set will be sent to NHS England for approval in the autumn.

* Are CCGs behaving differently to PCTs? If not, what's the point?

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus
Follow Us: